Credit Suisse’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.33M | Sell |
28,648
-1,483
| -5% | -$68.8K | ﹤0.01% | 2097 |
|
|
2023
Q4 | $2.04M | Buy |
30,131
+1,972
| +7% | +$133K | ﹤0.01% | 1864 |
|
|
2023
Q3 | $2.04M | Buy |
28,159
+2,550
| +10% | +$185K | ﹤0.01% | 1820 |
|
|
2023
Q2 | $1.91M | Sell |
25,609
-3,371
| -12% | -$251K | ﹤0.01% | 1931 |
|
|
2023
Q1 | $1.54M | Buy |
28,980
+6,554
| +29% | +$349K | ﹤0.01% | 2017 |
|
|
2022
Q4 | $1.52M | Buy |
22,426
+3,362
| +18% | +$227K | ﹤0.01% | 2030 |
|
|
2022
Q3 | $2.38M | Buy |
19,064
+1,529
| +9% | +$191K | ﹤0.01% | 1733 |
|
|
2022
Q2 | $1.67M | Buy |
17,535
+11,369
| +184% | +$1.08M | ﹤0.01% | 2026 |
|
|
2022
Q1 | $994K | Buy |
6,166
+2,743
| +80% | +$442K | ﹤0.01% | 2536 |
|
|
2021
Q4 | $1.14M | Buy |
+3,423
| New | +$1.14M | ﹤0.01% | 2504 |
|